Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Friday after the U.S. Food and Drug Administration announced a significant policy change that could reshape the drug development landscape.
Recursion Pharmaceuticals Shares Are Up Today: what’s Going On?
